Gencor to distribute Gnosis by Lesaffre’s Landkind Pure Salidroside in the United States

Photo © AdobeStock.com//lzf

Gencor (Austin, TX) has announced that it will be the exclusive U.S. distributor for a fermented salidroside bioactive, called Landkind Pure Salidroside. The ingredient is manufactured by Gnosis by Lesaffre as an alternative to rhodiola extract. Salidroside is the most studied bioactive in rhodiola, to which the extract efficacy is attributed to. Rhodiola is a threatened species due to overharvesting, and has been added to the Convention on International Trade in Endangered Species (CITES) list of Wild Fauna and Flora to ensure sustainable harvest and trade. Therefore, Landkind is marketed as an effective and sustainable alternative to the herbal extract.

“We are incredibly proud to add Gnosis’s sustainable, ethical, and clinically backed rhodiola bioactive to our sports nutrition portfolio,” said R.V. Venkatesh, co-founder and managing director at Gencor,in a press release. “We are passionate about providing groundbreaking ingredients with human clinical data to meet and exceed the needs of today’s and tomorrow’s consumers.”

“We selected Gencor as our partner because of their expertise, longevity, and honorable reputation in the industry,” said Nicole Lemus, Gnosis by Lesaffre director Americas. “At Gnosis, we believe that promoting well-being is as important as preserving our environment, a principle that begins with our production techniques. We are deeply passionate about preserving this botanical species and understand its great potential for human health. Through fermentation, we’ve ethically developed the most studied and main bioactive, salidroside, in a convenient, consistent nutraceutical for sports and active nutrition.”

According to the company, the ingredient has an effective dose of 60 mg per day. Research has shown that supplementation with Landkind Pure Salidroside significantly increase oxygen uptake during exercise.